Pharmaceutical

Pharmacy board narrowly accepts drug diversion settlement with IU Health’s Muncie hospital

July 14, 2026 | Casey Smith, Indiana Capital Chronicle

Indiana’s pharmacy regulators reluctantly approved the disciplinary settlement over what they describe as one of the largest known drug theft cases in state history.

Read More

7th Circuit restores breach-of-contract case against Eli Lilly

July 13, 2026 | Cameron Shaw, The Indiana Lawyer

The appellate court held that Teva plausibly alleged that Lilly breached the two companies’ 2018 settlement agreement, which stipulated that Lilly would not interfere with Teva getting approval for a generic version of Lilly’s osteoporosis drug, Forteo.

Read More

Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs

July 2, 2026 | Associated Press

Under the proposed rule, the Centers for Medicare & Medicaid Services would change the formula for what hospitals participating in the program can get reimbursed, in an effort to cut costs for patients.

Read More

Elanco working to manage parasitic fly’s arrival in U.S.

June 26, 2026 | Daniel Bradley

Elanco Animal Health Inc. is among the companies taking a leading role in combating the re-emergence of deadly New World screwworm that was pushed out of the United States six decades ago.

Read More

Eli Lilly suspends access to drug discounts for some hospitals

June 24, 2026 | Mackenzi Klemann, Indiana Capital Chronicle

The drugmaker is restricting access to a drug discount program intended for safety-net hospitals in a move the company says is needed to identify waste, fraud and abuse.

Read More

3 ways GLP-1 drugs could be getting better

June 11, 2026 | The Washington Post

A race is shaping up among drug manufacturers that are vying to roll out better options when it comes to weight-loss drugs.

Read More

Lilly’s 30% weight loss sets high bar for obesity drug race

June 8, 2026 | Bloomberg News

At the American Diabetes Association meeting in New Orleans, market leader Eli Lilly and Co. asserted its dominance in the weight-loss market.

Read More

The science involving GLP-1 drugs and cancer is getting much more interesting

June 4, 2026 | The Washington Post

After transforming the treatment of diabetes and weight loss, a growing body of research is raising the possibility that these drugs may help protect against cancer.

Read More

RayzeBio planning $150M in radiopharmaceutical facilities in Whitestown

June 1, 2026 | Elissa Maudlin

The company, which is owned by biopharmaceutical giant Bristol Myers Squibb Co., is working on an incentive package with Whitestown officials that includes tax abatements for construction and new equipment for two buildings.  

Read More

Lilly’s experimental GLP-1 pushes limits of weight loss, but there are risks

May 29, 2026 | The Washington Post

Eli Lilly and Co. this month unveiled startling new data for an experimental weight-loss drug. The breakthrough also is prompting some doctors to urge caution.

Read More

New weight-loss drugs may be reshaping the brain, scientists say

May 28, 2026 | The Washington Post

Tens of millions of people are now taking the medications worldwide, turning what began as obesity and diabetes treatments into what could be modern medicine’s largest unplanned neuroscience experiments.

Read More

Lilly spending nearly $4B to acquire three vaccine developers

May 26, 2026 | Daniel Bradley

The Indianapolis drugmaker is purchasing Curevo Inc., LimmaTech Biologics AG and Vaccine Co. Inc. to expand its research and development efforts in infectious disease.

Read More

Lilly goes on $21B buying spree to build drug pipeline

May 22, 2026 | Daniel Bradley

Deal after deal, Eli Lilly and Co. is using the fruits of its success from developing blockbuster GLP-1 medicines to prepare for its next chapter and build a bridge over a looming patent cliff.

Read More

Elanco’s newest medication enters $1.3B US itchy-dog market

May 20, 2026 | Daniel Bradley

The Indianapolis-based company has announced the phased launch of Befrena, a monoclonal antibody injection for treating canine allergic and atopic dermatitis.

Read More

Lilly rebuffed by Supreme Court on $194M Medicaid award

May 18, 2026 | Bloomberg News

The case against Lilly centered on the rebates that drug companies must pay to state Medicaid programs to subsidize some of the cost.

Read More

Lilly CEO David Ricks keeps eye on future while company celebrates history

May 13, 2026 | Daniel Bradley

The Indianapolis-based drugmaker is marking 150 years since Col. Eli Lilly founded his company on May 10, 1876.

Read More

Lilly looks to sell about $8B of debt to fund acquisitions

May 7, 2026 | Bloomberg News

The move comes as Lilly has embarked on a spree of large acquisitions, including two of its most-expensive transactions ever.

Read More

Elanco’s stock climbs after company posts strong 1st quarter results

May 6, 2026 | Joey Harris

Demand for drugs to combat ticks and other pests was a major factor boosting Elanco Animal Health Inc.’s first quarter results, company executives said Wednesday.

Read More

Lilly announces additional $4.5B investment at LEAP District manufacturing site

May 6, 2026 | Daniel Bradley

Lilly’s latest commitment at the LEAP District brings the company’s total investment there since 2022 to $18 billion.

Read More

Trump’s drugmaker deals could save economy $529B over 10 years, White House economists say

May 5, 2026 | Associated Press

The potential savings estimated would be substantial as Americans spent $467 billion on prescription drugs in 2024, according to the most recent government data available.

Read More